FGEN FibroGen (NASDAQ:FGEN) reported quarterly losses of $(0.98) per share which missed the analyst consensus estimate of $(0.81) by 20.99 percent. This is a 281.48 percent decrease over earnings of $0.54 per share from the same period last year. The company reported quarterly sales of $15.73 million which missed the analyst consensus estimate of $31.59 million by 50.19 percent. This is a 89.91 percent decrease over sales of $155.97 million the same period last year.

CHMF @Foolinvest.Me как Ваше мнение по Северстали? 3 недельных зеленых свечи подряд, от дна в 560 выросла на +48%.... неужели дивы хотят заплатить?

SBER @Soul_ где шорт "зеленого" будем откупать?)